PerkinElmer Files Suit Against Genomic Solutions.
The court filing is sealed, thus all the details of the case are unknown at this time. However, the suit raises interesting questions about the value of small life science companies such as Genomic Solutions to an investor such as PerkinElmer. In such a competitive marketplace, and with a low stock price, Genomic Solutions could be trying to secure its financial fooling, either by making PerkinElmer exercise its option or by seeking another investor.
|Printer friendly Cite/link Email Feedback|
|Comment:||PerkinElmer Files Suit Against Genomic Solutions.|
|Publication:||Instrument Business Outlook|
|Article Type:||Brief Article|
|Date:||Feb 15, 2001|
|Previous Article:||Bioinformatics: The Rosetta Stone of Life Science Research.|
|Next Article:||Rheometric to Exclusively Distribute Camtel Products.|